Where Discovery Becomes Diagnostic.

World class research.

Cutting-edge facilities.

Leading expertise.

Breakthrough discoveries.

Establishing an Advanced Radiotracer Production Facility in Hull

In partnership with the local NHS Trust and GE Healthcare, we have established a state-of-the-art research facility dedicated to the on-site production of radiotracers. This collaboration enables Hull to serve as a global reference centre for the GENtrace 600 small cyclotron—one of only four such machines worldwide.

The presence of this advanced cyclotron positions Hull at the forefront of dose-on-demand technologies. This capability significantly enhances the facility’s ability to produce tailored radiotracers rapidly, ensuring that patients receive customised diagnostic solutions with greater efficiency. Through these developments, we are advancing the potential for precision medicine and improving patient care by delivering innovative radiotracer solutions directly from our site.

See inside the MIRC

Watch this video and step behind the scenes of our facility to find out more about the people and equipment at the heart of the operation.

Enquire about partnership arrangements, the scope of our work, and the availability of our facilities

Fostering Translational Research and Biomarker Development

The PET facility in Hull will enable close collaboration between clinical experts and basic science researchers, creating an environment where a genuinely translational research programme can thrive. This integrated approach supports the seamless progression of discoveries from the laboratory into clinical practice.There are exciting prospects for developing PET biomarkers not only in the field of oncology, but also in neurology and cardiology. The facility’s cutting-edge technology provides the foundation for advancing these specific biomarkers, further enhancing diagnostic and therapeutic potential across multiple medical specialities.

Addressing the Need for Novel PET Biomarkers through Collaboration

There is a substantial clinical demand for the development of new and enhanced biomarkers in PET imaging. However, to meet this demand, it is essential to establish a clear translational pathway that bridges the gap between basic scientific discoveries and their application in clinical settings. A major motivation behind the Daisy Appeal’s commitment to advancing a fixed facility in Hull lies in the considerable opportunity it presents for collaborative research. This collaboration builds upon both new and existing PET-CT products, providing a strong foundation for scientific progress and clinical innovation in the field.

Registered office: MIRC, Daisy Building, Castle Hill Hospital, Castle Road, Cottingham HU16 5JQ.

Registered company number 177823472

Call: 01482 461909

Website by Design Workshop